Legal News

Global regulatory meeting held to discuss the progress of coronavirus (COVID-19) treatments

Published on: 06 April 2020
Published by LNB News

LNB News 06/04/2020

Document Information

Issue Date: 06 April 2020

Published Date: 06 April 2020

Jurisdiction(s): United Kingdom

Article summary

The European Medicines Agency has jointly chaired the second global regulatory meeting with the Japanese Pharmaceuticals and Medical Devices Agency to discuss the progress made in the development of coronavirus (COVID-19) treatments. Participants from more than 25 countries attended the meeting, including experts from the World Health Organization and the European Commission. The availability of coronavirus treatments and the need for large clinical trials in order to gain conclusive evidence on the treatments that work were discussed at the meeting.

Popular documents